Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bahrain begins child screening programme:

This article was originally published in Clinica

Executive Summary

Bahrain is to begin screening 6,000 children for diseases, including sickle cell anaemia, beta thalassaemia and glucose-6 phosphate dehydrogenase (G6PD) deficiency in March 2003. The project is funded by the Bahrain society for hereditary diseases (BSHD) to the tune of BD20,000 ($53,200) and has the backing of the ministries of health and education. BSHD has already begun purchasing the equipment required for the screening programme. It will take the total number of children screened in Bahrain over the past five years to 30,000. Bahrain's current infant screening programme has helped lower the number of children born with hereditary diseases from 2.1% in 1986 to 0.9% today, said Dr Al Arrayed of the Salmaniya Medical Complex genetics department, in Manama.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT060723

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel